Neurology Archives | Report Store

Market Spotlight: Myelofibrosis (MF)

Datamonitor Healthcare estimates that in 2019, there were 49,500 prevalent cases of myelofibrosis in adults aged 50 years and older worldwide, and forecasts that number to increase to 60,700 prevalent cases by 2028.

March 24, 2022

Find out more

Market Spotlight: Insomnia

$1,318.00

This Market Spotlight report covers the insomnia market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, key upcoming events and regulatory events, probability of success, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

March 17, 2022

Find out more

Market Spotlight: Fragile X Syndrome

$1,318.00

This Market Spotlight report covers the Fragile X Syndrome market, comprising key pipeline drugs, clinical trials, recent events and analyst opinion, probability of success, a discussion on disease epidemiology, and licensing and asset acquisition deals.

March 11, 2022

Find out more

Market Spotlight: Attention Deficit Hyperactivity Disorder (ADHD)

$1,318.00

This Market Spotlight report covers the Attention Deficit Hyperactivity Disorder (ADHD) market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, a 10-year disease prevalence forecast, as well as presenting drug-specific revenue forecasts.

March 10, 2022

Find out more

Market Spotlight: Cachexia

$1,318.00

Cachexia is a complex, multifactorial, and multi-organ metabolic syndrome found in the late stages of serious illnesses including cancer, kidney disease, and congestive heart failure.

March 8, 2022

Find out more

Market Spotlight: Amyotrophic Lateral Sclerosis (ALS)

$1,318.00

This Market Spotlight report covers the Amyotrophic Lateral Sclerosis (ALS) market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, recent events and analyst opinion, a 10-year disease incidence forecast, probability of success, and licensing and acquisition deals.

February 18, 2022

Find out more

Market Spotlight: Huntington’s Disease

$1,318.00

This Market Spotlight report covers the Huntington’s Disease market, comprising key marketed and pipeline drugs, clinical trials, upcoming events, recent events and analyst opinion, probability of success, licensing and asset acquisition deals, and a 10-year disease prevalence forecast, as well as presenting drug-specific revenue forecasts.

February 16, 2022

Find out more

Biomedtracker Meddevice Tracker Early 2022 Outlook Report

$4,750.00

Biomedtracker Meddevice Tracker Early 2022 Outlook Report

February 8, 2022

Find out more

Market Spotlight: Systemic Hypertension

$1,318.00

This Market Spotlight report covers the Systemic Hypertension market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

February 4, 2022

Find out more

Disease Analysis: Alzheimer’s Disease

Alzheimer’s disease is an irreversible, progressive, neurodegenerative disease that slowly affects memory, cognition, and function. It is a continuum of pathological changes in the brain that begin well before clinical symptoms emerge.

January 31, 2022

Find out more

Disease Analysis: Migraine

Migraine is a common, disabling, and recurring neurological disorder characterized by severe headache co-occurring with nausea, vomiting, and other symptoms, the duration of which can range from hours to days.

January 25, 2022

Find out more

Disease Analysis: Epilepsy

Epilepsy is characterized by recurrent, unprovoked seizures, and is one of the most common chronic neurological disorders globally. A seizure is a transient manifestation of signs and/or symptoms, including a disturbance of consciousness, emotion, behavior, or motor function, which occurs because of abnormal excessive or synchronous neuronal activity in the brain.

November 22, 2021

Find out more

Disease Analysis: Parkinson’s Disease

Parkinson’s disease (PD) is a chronic disorder characterized by movement abnormalities and other non-motor symptoms, such as dementia, depression, visual hallucinations, and autonomic dysfunction. Although not fatal, there is currently no cure for the disease, and its chronicity is associated with significant morbidity and disability.

October 28, 2021

Find out more

Disease Analysis: Multiple Sclerosis

Multiple sclerosis (MS) is an inflammatory, autoimmune disease characterized by neuronal demyelination leading to physical and cognitive disability.

October 7, 2021

Find out more

Neurointervention: Mechanical Thrombectomy Devices Market

$4,750.00

This medical market and technology report provides a comprehensive discussion of the global market for neurointerventional cerebral aneurysm and arteriovenous malformation (AVM) embolization systems.

October 30, 2020

Find out more

Neurology

Market Spotlight: Myelofibrosis (MF)

Market Spotlight: Insomnia

Market Spotlight: Fragile X Syndrome

Market Spotlight: Attention Deficit Hyperactivity Disorder (ADHD)​

Market Spotlight: Cachexia

Market Spotlight: Amyotrophic Lateral Sclerosis (ALS)

Market Spotlight: Huntington’s Disease

Biomedtracker Meddevice Tracker Early 2022 Outlook Report

Market Spotlight: Systemic Hypertension

Disease Analysis: Alzheimer’s Disease

Disease Analysis: Migraine

Disease Analysis: Epilepsy

Disease Analysis: Parkinson’s Disease

Disease Analysis: Multiple Sclerosis

Neurointervention: Mechanical Thrombectomy Devices Market

Market Spotlight: Attention Deficit Hyperactivity Disorder (ADHD)